Rubric Capital Management (New York)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-704,564
| Closed | -$2.96M | – | 71 |
|
|
2018
Q3 | $2.96M | Buy |
704,564
+99,360
| +16% | +$417K | 0.31% | 42 |
|
|
2018
Q2 | $2.34M | Hold |
605,204
| – | – | 0.23% | 37 |
|
|
2018
Q1 | $3.83M | Buy |
605,204
+83,784
| +16% | +$531K | 0.36% | 47 |
|
|
2017
Q4 | $4.21M | Buy |
521,420
+91,990
| +21% | +$742K | 0.52% | 40 |
|
|
2017
Q3 | $4.91M | Buy |
+429,430
| New | +$4.91M | 0.44% | 39 |
|